FDA 483 - Central California Blood Center/ Clovis Donor Center - December 11, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Central California Blood Center/Clovis Donor Center in Clovis, CA, identified two significant observations. The facility failed to provide adequate space for the orderly and clean storage of blood and blood components, leading to potential contamination risks. Additionally, phlebotomists were observed not consistently following written standard operating procedures for inverting sample tubes during blood collection, which could affect sample integrity.
- Inspection Date
- December 11, 2024
- Product Type
- Biologics
ID · 6b7fe1bc-87cb-4d6e-9858-0f81634464d9